Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients

Keyphrases

• Liver Failure 100%
• Liver Transplantation 100%
• Clinical Outcomes 100%
• Allograft 100%
• Lysosomal Acid Lipase 100%
• Disease Progression 30%
• Enzyme Replacement Therapy 30%
• Hepatopathology 30%
• Cirrhosis 20%
• Splenectomy 20%
• Liver Allograft 20%
• Post-liver Transplantation 20%
• Enzyme Activity 10%
• Pathophysiology 10%
• Monocyte-derived Macrophages 10%
• Recombinant 10%
• Liver Disease 10%
• Vascular Disease 10%
• Acute Rejection 10%
• Kupffer Cells 10%
• Recurrent Disease 10%
• Index Patient 10%
• Dyslipidemia 10%
• Advanced Fibrosis 10%
• Systemic Disease 10%
• Lipolytic Enzymes 10%
• FDA-approved Drugs 10%
• Multisystem Disease 10%
• Microvesicles 10%
• Hematopoietic Stem Cell Transplant 10%
• Young Sister 10%
• Liver Transplantation Outcomes 10%
• Fibrosis Diseases 10%
• Bone Marrow-derived Monocytes 10%
• Sebelipase Alfa 10%
• Macrophage Aggregates 10%
• Hematopoietic Stem Cell Transplantation 10%
• Lipid-lowering Medications 10%
• Microvesicular Steatosis 10%
• Progression Disease 10%
• Multisystemic 10%
• Micronodular 10%
• Hepatosteatosis 10%
• Foamy Macrophages 10%
• Therapy Development 10%

Medicine and Dentistry

• Liver Transplantation 100%
• Liver Failure 100%
• Recurrent Disease 100%
• Allograft 100%
• Acid Lipase 100%
• Disease Exacerbation 30%
• Enzyme Replacement Therapy 30%
• Liver Cirrhosis 20%
• Fibrosis 20%
• Macrophage 20%
• Splenectomy 20%
• Systemic Disease 20%
• Hematopoietic Stem Cell Transplantation 20%
• Liver Graft 10%
• Dyslipidemia 10%
• Pathophysiology 10%
• Vascular Disease 10%
• Systematic Review 10%
• Liver Disease 10%
• Acute Graft Rejection 10%
• Kupffer Cell 10%
• Steatosis 10%
• Infancy 10%
• Fatty Liver 10%
• Enzyme Activity 10%
• Sebelipase Alfa 10%
• Therapy Development 10%